Interest Paid, Excluding Capitalized Interest, Operating Activities of Cerevel Therapeutics Holdings, Inc. from 31 Mar 2023 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
Summary
Cerevel Therapeutics Holdings, Inc. quarterly and annual Interest Paid, Excluding Capitalized Interest, Operating Activities in USD history and change rate from 31 Mar 2023 to 31 Mar 2024.
  • Cerevel Therapeutics Holdings, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 31 Mar 2024 was $4,313,000, a 0.56% increase year-over-year.
Source SEC data
View on sec.gov
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Change (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)

Cerevel Therapeutics Holdings, Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $4,313,000 +$24,000 +0.56% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q1 2023 $4,289,000 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1

Cerevel Therapeutics Holdings, Inc. Annual Interest Paid, Excluding Capitalized Interest, Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $8,601,000 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.